A Comprehensive Evaluation of the Anti-hyperglycemic Activity of Callistemon citrinus(Curt): HPLC Fingerprint Analysis and Its Association with the Biological Activity of Phytochemical Constituents
DOI:
https://doi.org/10.54172/65pxww67Keywords:
Callistemon citrinus ; Phytochemical ; Phenolic Compounds ; HPLC-DAD chromatogram ; Blood glucoseAbstract
Hyperglycemia is a main metabolic disorder associated with type 2 diabetes mellitus and plays a critical role in the growth of serious complications, including cardiovascular diseases, neuropathy, and renal dysfunction. In current years, increasing attention has been directed toward natural products with low toxicity as alternative or complementary therapeutic agents, particularly medicinal plants rich in bioactive compounds capable of modulating glucose homeostasis. Callistemon citrinus is known as aappreciated source of flavonoids, phenolic acids, and terpenoids, compounds known for their antioxidant properties and their ability to inhibit carbohydrate-digesting enzymes such as α-amylase and α-glucosidase.The current study aimed to characterize the phytochemical fingerprint of C. citrinus leaf extract using high-performance liquid chromatography (HPLC), to evaluate its antihyperglycemic activity, and to explore the relationship between chemical composition and biological efficacy. Phenolic compounds were extracted using an aqueous–methanolic solvent system and identified through comparison with authenticated reference standards. In vitro assays were conducted to assess the inhibitory effects of the extract against α-amylase and α-glucosidase at different concentrations.HPLC analysis resulted in the separation and identification of nine major phenolic compounds, with quinic acid being the predominant constituent, accounting for 56.1% of the total phenolic content. The extract exhibited a pronounced inhibitory effect on α-glucosidase, reaching 82% inhibition at the highest tested concentration, while α-amylase inhibition reached up to 70%. Correlation analysis revealed a strong connotation between the high phenolic content, particularly quinic and cinnamic acids, and the observed enzyme inhibitory activity.
References
Ali, S., Saleem, M., & Siddiqui, B. S. (2020). Phytochemical profile and biological activities of Callistemon citrinus. Journal of Medicinal Plants, 12(3), 45–56.
American Diabetes Association. (2023). Standards of medical care in diabetes—2023. Diabetes Care, 46(Suppl. 1), S1–S154.
Boerjan, W., Ralph, J., & Baucher, M. (2003). Lignin biosynthesis. Annual Review of Plant Biolo-gy, 54, 519–546.
Clifford, M. N. (1999). Chlorogenic acids and other cinnamates. Journal of the Science of Food and Agriculture, 79(3), 362–372.
Dai, J., & Mumper, R. J. (2010). Plant phenolics: Extraction, analysis and their antioxidant and an-ticancer properties. Molecules, 15(10), 7313–7352.
ElSayed, S., & Abdelrahman, M. (2022). HPLC applications for plant phenolic analysis. Phyto-chemistry Letters, 45, 101–110.
Fayemi, O. E., et al. (2019). In vitro α-glucosidase inhibition by Callistemon citrinus extracts. Jour-nal of Ethnopharmacology, 244, 112–120.
Gupta, R., et al. (2019). Plant-derived α-amylase and α-glucosidase inhibitors: Role in diabetes management. Phytotherapy Research, 33(4), 854–868.
Herrmann, K., & Weaver, L. (1999). Phenolic acids in foods. Journal of Agricultural and Food Chemistry, 47(3), 1010–1021.
Ignat, I., Volf, I., & Popa, V. I. (2011). A critical review of methods for characterization of poly-phenols in plants. Trends in Analytical Chemistry, 30(9), 1003–1024.
Jafri, S. M. H., & El-Gadi, A. M. (1986). Flora of Libya. Tripoli University Press.
Kumar, R., et al. (2020). Antidiabetic activity of stem and root extracts of Callistemon citrinus. Di-abetes & Metabolic Syndrome: Clinical Research & Reviews, 14(6), 2007–2014.
Landete, J. M. (2011). Ellagic acid: Metabolism, health effects and food sources. Food Research International, 44(5), 1150–1160.
Li, X., et al. (2021). Anthocyanins and flavonoids from Callistemon citrinus: HPLC-DAD-ESI-MS/MS profiling and antioxidant activity. Journal of Functional Foods, 77, 104348.
Mohamed, A., & Salem, F. (2024). Correlation between phenolic composition and biological activi-ty of medicinal plants. Phytomedicine, 106, 154407.
Papoutsi, Z., et al. (2008). Ellagic acid: Antioxidant, anti-inflammatory and anticancer properties. Journal of Agricultural and Food Chemistry, 56(19), 8670–8676.
Robbins, R. J. (2003). Phenolic acids in foods: An overview. Journal of Agricultural and Food Chemistry, 51(10), 2866–2887.
Routray, W., & Orsat, V. (2012). Ultrasound-assisted extraction of phenolic compounds from plant materials. Food Chemistry, 130(2), 543–550.
Salem, N., et al. (2017). Taxonomic description of Callistemon viminalis. Australian Journal of Botany, 65(4), 289–300.
Sharma, P., & Gupta, R. (2020). Medicinal plants as antidiabetic agents. Journal of Diabetes Re-search, 2020, 1234567.
Siddiqui, S., et al. (2023). Phytochemical and antioxidant profiling of Callistemon citrinus. Phyto-chemistry, 205, 113476.
Srivastava, R., et al. (2003). Distribution and ecology of Callistemon viminalis. Botanical Journal of the Linnean Society, 142(3), 315–326.
Vogt, T. (2010). Phenylpropanoid biosynthesis. Molecular Plant, 3(1), 2–20.
Published
Issue
Section
License
Copyright (c) 2026 Fatima Mohamed Emeetteg, Nizar Adim Dabr, Muftah Altayeab Krayem, Siham Mohamed Al-Shikindi, Mohammed Alwshish, Rania Farag Mohammed, Hajar Mohammed Qusaibat (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of the articles Published by Al-Mukhtar Journal of Basic Sciences (MJBS) is retained by the author(s), who grant MJBS a license to publish the article. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors and cite MJBS as the original publisher. Also, they accept the article remains published by the MJBS website (except in the occasion of a retraction of the article). All MJBS Published articles under the Attribution-NonCommercial 4.0 International License.



